Helen of Troy Limited (HELE) Bundle
You're looking at Helen of Troy Limited (HELE) and wondering if the Reset & Revitalize strategy is actually taking hold, especially after a challenging fiscal 2025 that saw consolidated net sales revenue drop to $1.908 billion, a 4.9% decline from the prior year. Honestly, the headline numbers are mixed: while the company delivered non-GAAP adjusted diluted EPS of $7.17, the GAAP diluted EPS was only $5.37, heavily impacted by a $51.5 million non-cash asset impairment charge in the fourth quarter, mostly tied to the Drybar business, which tells you where the pain points are. The near-term opportunity is in their cash flow-they generated a solid $83.1 million in free cash flow for the year, which is crucial for tackling their $916.9 million in total debt, but the risk remains consumer softness and the need to show that Project Pegasus cost-saving initiatives can consistently translate into organic growth, not just margin defense.
Revenue Analysis
You're looking for a clear picture of where Helen of Troy Limited (HELE) actually makes its money, especially after a challenging year. The direct takeaway is that while the Beauty & Wellness segment remains the largest contributor, the company's total net sales for fiscal year 2025 contracted, signaling continued consumer softness and internal headwinds. Total consolidated net sales revenue for the year ended February 28, 2025, came in at $1.908 billion, a year-over-year decline of 4.9% from the prior fiscal year.
This revenue contraction is a clear sign of the pressures on the consumer discretionary space, but it also reflects specific issues like the operational disruption at the Tennessee distribution facility early in the year. Honestly, a nearly 5% drop in top-line revenue is a headwind that requires decisive action, which is what their 'Reset and Revitalize' strategy aims to address.
Segment Contribution and Primary Sources
Helen of Troy Limited's revenue is fundamentally split between two consumer product segments. The primary revenue sources are the sales of branded consumer products, with the split being nearly even, though Beauty & Wellness holds the slight edge in FY2025. This diversification is a strength, but both segments faced distinct challenges.
- Beauty & Wellness: Contributed approximately $1.001 billion, or 52.5% of total net sales. This segment includes brands like Vicks, Braun, Hot Tools, and the newly acquired Olive & June.
- Home & Outdoor: Contributed approximately $906.2 million, or 47.5% of total net sales. Key brands here are OXO, Hydro Flask, and Osprey.
Here's the quick math on how the two segments stacked up in the last fiscal year:
| Segment | FY 2025 Net Sales (Approx.) | Contribution to Total Revenue |
|---|---|---|
| Beauty & Wellness | $1.001 Billion | 52.5% |
| Home & Outdoor | $906.2 Million | 47.5% |
Noteworthy Shifts in the Revenue Mix
The most significant change in the revenue streams is the ongoing struggle in the Beauty & Wellness segment's organic business (sales excluding acquisitions). While the segment's Q4 sales saw a slight increase of 0.1%, this was entirely due to the contribution from the Olive & June acquisition, which added $23.0 million in that quarter alone. What this estimate hides is the underlying weakness: the core Beauty business, especially hair appliances, is facing softer consumer demand and increased competitive intensity. The Home & Outdoor segment, which includes high-margin brands like Hydro Flask, also saw pressure from lower insulated beverageware sales and retailer inventory rebalancing. Still, Home & Outdoor showed resilience, with Q3 net sales actually increasing by 4.3% due to strength in international markets and all three of its major brands.
For a deeper dive into the ownership structure behind these numbers, you might want to read Exploring Helen of Troy Limited (HELE) Investor Profile: Who's Buying and Why?
The clear action for investors is to track the performance of the core organic business, particularly in Beauty & Wellness, as the acquisition boost will annualize. The management team needs to defintely show that their brand revitalization efforts can overcome the soft consumer environment.
Profitability Metrics
You want to know if Helen of Troy Limited (HELE) is making money efficiently, and the quick answer is yes, but the GAAP numbers are ugly right now. The company's full fiscal year (FY) 2025 results show a solid gross margin, but a non-cash asset impairment charge hammered the reported operating and net profits.
For FY 2025, which ended February 28, 2025, Helen of Troy Limited reported consolidated net sales revenue of $1.908 billion. Here's the quick math on their core profitability ratios for that period:
- Gross Profit Margin: 47.9%
- GAAP Operating Margin: 7.5%
- Adjusted Operating Margin (Non-GAAP): 13.2%
The gross margin is strong, but the huge gap between the GAAP and Adjusted Operating Margin tells the real story of the year. The GAAP (Generally Accepted Accounting Principles) operating margin of 7.5% was dramatically pulled down by a $51.5 million non-cash asset impairment charge in the fourth quarter. That's a one-time hit, but it's defintely a real loss that reflects a necessary write-down of asset values, mostly in the Beauty & Wellness segment.
Operational Efficiency and Cost Management
The good news is that operational efficiency is actually improving where it counts: the cost of goods sold (COGS). The gross profit margin actually improved by 60 basis points in FY 2025 to 47.9% compared to FY 2024. This is a direct result of lower commodity and product costs, plus the ongoing benefits from their multi-year cost-savings program, Project Pegasus. This project is a clear action item, targeting total annualized pre-tax operating profit improvements of $75 million to $85 million by the end of fiscal 2027. For FY 2025 alone, Project Pegasus was on track to deliver savings in the range of $26 million to $30 million. That's a tangible return on their efficiency efforts.
When you look at the industry, Helen of Troy Limited's gross margin of 47.9% is competitive for a branded consumer products company. For comparison, the average gross profit margin for the Apparel Manufacturing industry-a decent proxy for branded consumer goods-was around 49.3% as of November 2025. Their margin sits right in that healthy 30-50% range that's considered good for retail and consumer-facing businesses. The challenge isn't the cost to make the product, it's the cost to sell it and the non-cash write-offs.
| Profitability Metric | Helen of Troy (HELE) FY 2025 | Industry Average Proxy (Nov 2025) |
|---|---|---|
| Gross Profit Margin | 47.9% | 49.3% (Apparel Manufacturing) |
| Adjusted Operating Margin | 13.2% | N/A (Highly variable) |
| Net Profit Margin (Valuation Input) | ~6.97% | 2% to 10% (General Retail Guide) |
The net profit margin, which is the bottom line after all expenses and taxes, is the most volatile. While the full-year GAAP diluted earnings per share (EPS) was $5.37, a recent valuation analysis in November 2025 used a projected net profit margin of 6.97% for the company. This is a reasonable number, sitting well within the healthy 2% to 10% range for general retail and consumer businesses. The key action here is to monitor the GAAP net income in the coming quarters to see if the impairment charge is truly a one-off event. For a deeper dive into the company's long-term strategy, you should review the Mission Statement, Vision, & Core Values of Helen of Troy Limited (HELE).
Debt vs. Equity Structure
You need to understand how Helen of Troy Limited (HELE) funds its operations, because the mix of debt and equity tells you a lot about risk and potential return. For fiscal year 2025, which ended in February, the company's financing was relatively balanced, but the near-term trend shows a significant shift toward higher leverage.
The company ended fiscal year 2025 with a total debt of $916.894 million against total stockholders' equity of $1,683.439 million. This means the majority of the company's capital structure was equity-funded at that point. However, by the second quarter of fiscal year 2026 (ending August 2025), total debt was still high at $893.2 million, but total equity had dropped significantly, pushing the financial leverage higher.
Here's the quick math on the debt breakdown:
- Long-term debt is the primary component of their borrowing. For the fiscal year 2025 calculation, long-term debt and capital lease obligations were approximately $947.468 million, dwarfing the short-term portion of around $9.375 million.
- This reliance on long-term debt suggests a strategy to secure financing for extended periods, likely to fund strategic initiatives like acquisitions or capital expenditures, rather than managing immediate liquidity gaps.
The key metric here is the debt-to-equity (D/E) ratio, which measures financial leverage (Total Debt / Total Equity). For the full fiscal year 2025, Helen of Troy Limited's D/E ratio was 0.57. This level was comfortably below the industry averages for its key segments, indicating a conservative use of debt relative to peers at that time.
| Metric | HELE FY2025 Value | Industry Average (2025) | Leverage Posture |
|---|---|---|---|
| Debt-to-Equity Ratio | 0.57 | Household Products: 0.9008 | Below Industry Average |
| Total Debt | $916.894 million | N/A | N/A |
| Total Equity | $1,683.439 million | N/A | N/A |
But here's the crucial near-term risk: the D/E ratio jumped to 1.01 as of August 2025. This dramatic shift in the first half of fiscal year 2026 was driven by a sharp reduction in stockholders' equity, not just an increase in debt. This elevated D/E ratio is now above the Household Products industry average of 0.9008 and the Personal Care Products average of 0.6613.
The company balances its growth between debt financing and equity funding, but recent activity leans heavily on debt. The acquisition of Olive & June in December 2024, for example, cost $229.4 million, which was funded by cash and existing credit facilities, contributing to the overall debt load. While the company is actively focused on paying down debt and was in compliance with all covenants under its credit agreement as of August 31, 2025, the net leverage ratio (as defined by its credit agreement) has risen to 3.5x in the second quarter of fiscal 2026. This is a high number that warrants close monitoring, especially in a soft consumer demand environment.
The balance sheet is defintely more leveraged now than it was at the end of the last fiscal year. To get a deeper dive into the company's strategic direction that influences this capital structure, you should review the Mission Statement, Vision, & Core Values of Helen of Troy Limited (HELE).
Liquidity and Solvency
You need to know if Helen of Troy Limited (HELE) can cover its near-term bills, especially as they navigate a tough consumer environment. The quick takeaway is that while their overall liquidity ratio looks solid, the quality of that liquidity-what's tied up in inventory-shows a less comforting picture, and operating cash flow saw a sharp decline in fiscal year 2025.
Their headline liquidity position, measured by the current ratio (current assets divided by current liabilities), is decent. For the full fiscal year 2025 (ended February), Helen of Troy Limited reported a current ratio of 2.0. This means they have $2.00 in current assets for every dollar of current liabilities, which is a healthy buffer and an improvement from 1.87 in the prior fiscal year. That's a good starting point.
But here's the reality check: the quick ratio (or acid-test ratio) strips out inventory, which is often the least liquid current asset. We don't have the final quick ratio, but given the inventory levels, it's defintely a concern. The company's inventory was substantial, sitting at $450.7 million in the third quarter of fiscal 2025. If a slowdown forces deep discounts to move that product, the quick ratio-the real measure of immediate, high-quality liquidity-is far lower than 2.0. You must monitor inventory turnover closely; too much slow-moving stock is a cash drain.
Working Capital and Cash Flow Trends
The working capital trend shows management is actively trying to improve efficiency, but the cash flow statement reveals the strain. Working capital is current assets minus current liabilities, and while the ratio improved, the underlying components are volatile. Management is focused on improving working capital efficiencies and balance sheet productivity.
The cash flow statements highlight the biggest near-term risk. Net cash provided by operating activities for the full fiscal year 2025 plummeted to $113.2 million, a significant drop from the $306.1 million generated in fiscal 2024. That's a massive reduction in the cash fuel for the business, largely due to lower operating income and working capital movements.
Here's a quick cash flow overview for FY2025:
- Operating Cash Flow: $113.2 million (A significant year-over-year decline).
- Investing Cash Flow: Capital and intangible asset expenditures were expected to be between $30 million and $35 million. This is cash used to maintain and grow the business.
- Financing Cash Flow: Total debt increased to $917 million by the end of the fiscal year, with the net leverage ratio just under 3.0x. This increase was primarily to fund the acquisition of Olive & June in December 2024.
The drop in operating cash flow is a clear liquidity concern, forcing the company to rely more on its balance sheet strength and new debt to fund growth, like the Olive & June acquisition. The debt increase is manageable for now, but the net leverage ratio of just under 3.0x is a sign that the balance sheet is being stretched. The key is whether their restructuring plan, Project Pegasus, delivers the promised annualized pre-tax operating profit improvements of approximately $75 million to $85 million to stabilize that operating cash flow.
For a deeper dive into the company's strategic position, check out the full analysis: Breaking Down Helen of Troy Limited (HELE) Financial Health: Key Insights for Investors
Valuation Analysis
You are looking at Helen of Troy Limited (HELE) at a pivotal time. The stock has seen a massive decline, which has pushed its valuation metrics into territory that screams 'undervalued' based on book assets, but the negative earnings tell a more cautious story. Honestly, this is a classic value trap signal versus a deep-value opportunity, so we need to look past the surface-level multiples.
The stock price trend over the last 12 months is the first thing to note: a sharp decrease of around 73.89%, with the stock trading near $18.15 as of late November 2025. This drop reflects the market's reaction to recent financial challenges. The question is whether the stock is cheap enough to warrant the risk.
Here's the quick math on the key valuation ratios based on the latest available data for the 2025 fiscal year:
- Price-to-Earnings (P/E) Ratio: The LTM (Last Twelve Months) P/E is around -0.7x. This is not a meaningful metric for comparison, as a negative P/E simply means the company has negative net earnings over the past year. You can't compare a negative number to a sector average.
- Price-to-Book (P/B) Ratio: This is where it gets interesting. The P/B ratio is a low 0.45. This means the stock is trading at less than half its book value per share of $40.34 (as of August 2025). Historically, a P/B below 1.0 suggests potential undervaluation, but this metric can be skewed by intangible assets.
- Enterprise Value-to-EBITDA (EV/EBITDA): The LTM EV/EBITDA multiple is approximately 6.10x. This is a relatively low multiple, suggesting the company's operating cash flow (before debt, taxes, etc.) is cheap compared to its total enterprise value (market cap plus debt, minus cash). For context, consumer products companies often trade higher.
The low P/B and EV/EBITDA multiples suggest deep-value territory, but the negative P/E and stock price plunge show the market is pricing in significant operational risk. You should also review the Mission Statement, Vision, & Core Values of Helen of Troy Limited (HELE) to understand the strategic direction they are taking to address these challenges.
Analyst Sentiment and Dividend Policy
The analyst community is defintely cautious. The consensus rating for Helen of Troy Limited (HELE) is a split between 'Hold' and 'Reduce' (which is essentially a soft 'Sell'). Specifically, the breakdown shows two analysts with a 'Sell' recommendation and three with a 'Hold' recommendation. That's not a ringing endorsement.
The average price target is significantly higher at $42.00, which is over 100% above the current price. This suggests that while analysts see a path to recovery, they are unwilling to recommend a 'Buy' until they see concrete evidence of that turnaround. The risk is high, but so is the potential reward if the company executes its plan.
Regarding income, Helen of Troy Limited (HELE) does not currently pay a dividend, so the dividend yield and payout ratio are not applicable. This is common for companies prioritizing debt reduction and internal investment over shareholder distributions during a challenging period.
| Valuation Metric | Value (LTM/FY2025) | Interpretation |
|---|---|---|
| Stock Price (Nov 2025) | ~$18.15 | Down 73.89% over the last 12 months. |
| Price-to-Earnings (P/E) | -0.7x | Not meaningful; reflects negative net income. |
| Price-to-Book (P/B) | 0.45 | Significantly below 1.0; suggests asset-based undervaluation. |
| EV/EBITDA | 6.10x | Relatively low for the sector; suggests cheap operating cash flow. |
| Analyst Consensus | Reduce / Hold | Cautious outlook with a high average price target of $42.00. |
Your action here is to look closely at the balance sheet and cash flow statement, not the income statement. The low P/B and EV/EBITDA are your entry points, but the negative earnings are your near-term risk. Finance: track quarterly EBITDA margin improvements against the FY2025 outlook of $292 million to $295 million in Adjusted EBITDA.
Risk Factors
You're looking at Helen of Troy Limited (HELE) and seeing the brand strength, but you need to know where the financial foundation is stressed. Honestly, the biggest near-term headwinds for the company are a triple threat: geopolitical trade policy, a highly leveraged balance sheet, and a cautious consumer. The market is defintely nervous, which is why the company withheld its full-year fiscal 2026 guidance.
The core external risk is the evolving global trade policy, specifically the impact of tariffs. This uncertainty has caused significant operational disruption, forcing the company to pause direct import orders from China in the short term. For the full fiscal year 2025, consolidated net sales revenue was $1.908 billion, a decrease of 4.9%, with tariff-related issues being a major contributor to the sales decline in the subsequent quarter.
Here's a quick look at the major risks and the company's response:
- Tariff Disruption: Unmitigated tariff costs and related supply chain uncertainty.
- Consumer Softness: Broad demand decline in discretionary categories like insulated beverageware.
- Customer Concentration: Sales to the top five customers account for nearly half of total revenue.
- High Debt Load: Total debt was $917 million at the close of Q4 Fiscal 2025.
Operational and Financial Headwinds
The operational and financial risks are showing up clearly in the numbers. In Q4 of fiscal 2025, the company recorded a massive $51.5 million in non-cash asset impairment charges, primarily related to the Drybar business, which hammered the GAAP operating margin. Plus, the company's dependence on a few large customers, including Amazon, Walmart, and Target, means they have limited pricing power when facing cost inflation or tariffs.
The financial pressure is also visible in the margin compression. The consolidated gross profit margin decreased by 40 basis points year-over-year in Q4 2025, settling at 48.6%. This was due to a less favorable product and customer mix. Adjusted diluted earnings per share (EPS) for Q4 2025 came in at $2.33, down from the prior year, partly due to higher interest expense from the debt load.
To be fair, the company is not sitting still. Management is executing Project Pegasus, a restructuring initiative, which is helping to drive lower commodity and product costs, partially offsetting the margin squeeze.
Mitigation Strategies and Supply Chain Shift
The most critical mitigation strategy is the aggressive move to diversify the supply chain away from China. Helen of Troy Limited expects to reduce the cost of goods sold exposed to China tariffs to less than 20% by the end of fiscal 2026. This is a huge, multi-year undertaking, but it's the right strategic move to insulate the business from future trade volatility. They believe they can offset 70% to 80% of the tariff impact in fiscal 2026 through these efforts and other cost reductions.
The company is also focused on cost containment, controlling discretionary spending, and re-evaluating their product portfolio (SKU prioritization) to emphasize higher-margin products. This is a classic playbook move when facing a slowdown, but execution is everything. You should monitor the progress of this supply chain transition closely; if onboarding takes 14+ days for new suppliers, churn risk rises.
For more on the long-term vision guiding these decisions, you can read the Mission Statement, Vision, & Core Values of Helen of Troy Limited (HELE).
Growth Opportunities
You're looking for a clear map of where Helen of Troy Limited (HELE) goes from here, especially after a challenging fiscal 2025 (FY2025). The direct takeaway is this: the company is aggressively cutting costs to fund innovation and brand investment, but the near-term financial outlook for fiscal 2026 (FY2026) is tough, projecting a significant earnings drop. Your focus needs to be on the long-term strategic shift, not the next two quarters.
HELE's strategy is built on two pillars: Project Pegasus and Elevate for Growth. Project Pegasus is the global restructuring plan, which delivered its largest year of savings in FY2025, contributing to a 60 basis point increase in gross margin. This is all about operational efficiency, creating what they call 'fuel' for future growth investments. They expect this project to generate annualized pre-tax operating profit improvements of approximately $75 million to $85 million by the end of fiscal 2027. That's defintely a substantial boost to the bottom line.
The real growth driver is the multi-year Elevate for Growth plan (FY2025-2030), which centers on leveraging their portfolio of market-leading 'Leadership Brands' like OXO, Hydro Flask, and Osprey. This isn't corporate fluff; it means doubling down on product-driven growth and strengthening key retailer partnerships. For example, the acquisition of the omnichannel nail care brand Olive & June is already contributing to net sales, helping to offset declines in other areas.
Here's a quick look at the core growth drivers and competitive advantages positioning the company:
- Product Innovation: Allocating more investment to breakthrough innovation, like the soft-launched Drybar all-inclusive styler.
- International Expansion: Growing net sales internationally by 5.3% in FY2025, reflecting expanded distribution in multiple 'must-win' markets.
- Brand Portfolio Strength: Seven of their brands hold a number one or number two position in their respective U.S. measured categories.
- Acquisition Impact: The Olive & June acquisition is expected to significantly enhance revenue growth and adjusted earnings per share.
The company reported consolidated net sales revenue of $1.908 billion for the full fiscal year 2025. However, the near-term outlook reflects ongoing consumer spending softness and macroeconomic uncertainty. For fiscal 2026, the company projects consolidated net sales between $1.739 billion and $1.780 billion, an expected decline of 6.7% to 8.8%. This is the realistic headwind right now. Adjusted Diluted EPS is also expected to decline sharply, projected at $3.75 to $4.25 for FY2026, down from $7.17 in FY2025.
What this estimate hides is the strategic reinvestment. They are taking a short-term earnings hit to fund the long-term strategy, a trade-off I've seen work many times. The expected decline is partly due to a more promotional environment and consumer trade-down behavior. Still, the long-term value is tied to the successful execution of their Mission Statement, Vision, & Core Values of Helen of Troy Limited (HELE)., which focuses on brand health and operational excellence.
The financial health map looks like this:
| Metric | Fiscal Year 2025 Actual | Fiscal Year 2026 Outlook (Future Estimate) |
|---|---|---|
| Consolidated Net Sales | $1.908 billion | $1.739-$1.780 billion |
| Adjusted Diluted EPS | $7.17 | $3.75-$4.25 |
| Adjusted EBITDA Margin | 15.2% | N/A (Focus on Net Sales/EPS decline) |
The competitive advantage lies in their diversified portfolio across Home & Outdoor and Beauty & Wellness. When one segment faces a headwind, like the decline in Beauty hair appliance sales, the strength in another-like the growth in Wellness, OXO, and Osprey-provides a critical buffer. This diversification, plus the cost savings from Project Pegasus, is what positions them to weather the current consumer landscape and eventually deliver on the Elevate for Growth plan.
Next Step: Portfolio Managers should model a recovery timeline for HELE's Adjusted EPS, assuming successful execution of Project Pegasus cost savings and a return to modest organic growth in the second half of fiscal 2026.

Helen of Troy Limited (HELE) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.